Prospective observational analysis of circulating metabolites and kidney cancer risk We identified 25 metabolites robustly associated with kidney cancer risk (i.e., metabolites associated with risk after correction for multiple testing in the pooled analysis and nominally significant in at least 2 cohorts; Fig 2 , Table 2 ).
← all excerpts
The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium.
1
—
—